Skip to content
Proteso logo — Exoskeletons for industrial workers | It’s you, only safer

Proteso

Exoskeletons for industrial workers | It’s you, only safer

Founded 2022 Italy Italy 6 employees Pre-Seed Hardware, Manufacturing +1

General Information

Company Name Proteso
Founded Year 2022
Location Italy Italy
Employees 6
Industries Hardware, Manufacturing, Robotics
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Proteso. To contact Proteso, visit proteso.it.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Proteso compare?

A PDF of Proteso and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Proteso soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Proteso

Proteso is a deep-tech startup and spin-off of the Italian Institute of Technology (IIT), specializing in exoskeletons for industrial workers. The company's mission is to design and produce intuitive and comfortable exoskeletons that enhance worker safety and well-being across various industrial sectors. Leveraging 8 years of R&D experience, Proteso is poised to transform its exoskeleton technology into successful products.

Founded in 2022 and headquartered in Italy, Proteso recently secured a Pre Seed Round investment on 30 September 2023 from ADR Ventures. The investment speaks volumes about the potential of Proteso's innovative approach to addressing the challenges faced by industrial workers. With a focus on hardware, manufacturing, and robotics, Proteso is well-positioned to make a significant impact in the industrial technology space. As the company continues to develop and launch its products, its ability to create effective solutions for worker safety and productivity will be closely watched by the industry and investors alike.

Business keywords: exoskeletons, wearable technology, industrial safety, worker health, productivity enhancement, R&D, manual material handling, physiological effects, IIT spin-off, deep-tech startup, innovation, worker ergonomics, injury prevention, industrial sectors, ergonomics

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 1
ADR Ventures
30 Sep 2023
Pre Seed Round Undisclosed 1
B4i - Bocconi for innovation
01 Oct 2022

Proteso Alternatives & Competitors

Proteso vs

Human-centric robotics that augment human strength, protect health and redefine physical work throug...

Series A
54 employees
AI, Automation
Proteso vs

Made in the USA. Proudly supporting both Military and Commercial Clients

16 employees
Industrial, Manufacturing

FAQ About Proteso

Exoskeletons for industrial workers | It’s you, only safer
Proteso was founded in 2022.
Proteso is headquartered in Italy.
Proteso operates in Hardware, Manufacturing and Robotics. Its work centres on exoskeletons, wearable technology, industrial safety and worker health.
Proteso has approximately 6 employees.
Proteso has completed 2 funding rounds. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Proteso include German Bionic, Temple Allen Industries. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Proteso and German Bionic are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Proteso, https://www.bouncewatch.com/company/proteso, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout